GlassScriptPhysician profile
Khaled F Basiouny
NPI 1467657890
$288.85
in general payments reported to CMS, 2019-2025
8 companies · $54.85 in 2025
The $54.85 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $30.96 · 2023: $19.00 · 2025: $54.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $112.37 | 2019 | |
| Z-Medica, LLC | $35.67 | 2019 | |
| Integra Lifesciences Corporation | $32.07 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $30.96 | 2021 | |
| Merck Sharp & Dohme LLC | $22.78 | 2025 | Zerbaxa |
| Kerecis Limited | $19.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kls-Martin L.P. | $18.36 | 2019 | |
| Ucb, INC. | $17.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Basiouny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.